Putnam Investments LLC Mirum Pharmaceuticals, Inc. Transaction History
Putnam Investments LLC
- $73 Billion
- Q4 2023
A detailed history of Putnam Investments LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 107,005 shares of MIRM stock, worth $4.21 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
107,005Holding current value
$4.21 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
172Shares Held
54.2MCall Options Held
96.1KPut Options Held
54.8K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$256 Million13.09% of portfolio
-
Janus Henderson Group PLC London, X04.99MShares$196 Million0.09% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$172 Million4.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.61MShares$142 Million2.18% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$127 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.45B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...